Srinivasan Mukundan Michael L Steigner Li-Li Hsiao Sayeed K Malek Stefan G Tullius Matthew S Chin Andrew M Siedlecki
10.1053/j.ajkd.2015.12.017
Am J Kidney Dis
2016 Jun;67(6):984-8.
ferumoxytol chronic kidney disease (ckd) contrast agent magnetic resonance angiography (mra) magnetic resonance imaging (mri) renal failure ultra-small superparamagnetic iron oxide (uspio)
author_manuscript
https://pubmed.ncbi.nlm.nih.gov/26786296/
Contrast Media Ferrosoferric Oxide Magnetic Resonance Imaging / methods Renal Insufficiency, Chronic / diagnostic imaging
Contrast Media Ferrosoferric Oxide Magnetic Resonance Imaging / methods Renal Insufficiency, Chronic / diagnostic imaging Case Reports Adult Female Humans Radiographic Image Enhancement Severity of Illness Index Contrast Media Ferrosoferric Oxide
PMC4877283
26786296
Ferumoxytol-Enhanced Magnetic Resonance Imaging in Late-Stage CKD
2016